Bayer MaterialScience exhibits at PDM 2012, ExCel London
On display was an electric car charging station. The continued advancement of electric mobility depends not only on the efficient design and equipping of electric cars, but also on the establishment of a suitable infrastructure. The Dutch company EV-Box, for instance, manufactures charging stations with a housing made of a halogen-free, flame retardant grade of Bayblend® polycarbonate blend.
The BMS team could also talk about the increasing demand for lightweight designs in the automotive industry, the aim being to cut fuel consumption, costs and CO2 emissions. Bayer’s Makrolon®-brand polycarbonates have already proven effective in transparent glazing solutions for the production of vehicles. Current trends include roof modules and panoramic roofs all the way to design solutions for complete modules, such as rear hatches. Compared to conventional glass technology, the weight of such components can be reduced by as much as 50 percent.
Another innovative display was an LED streetlight. Optical lenses made of Makrolon® polycarbonate focus and direct the light of LEDs in automotive headlamps and streetlights. Effectively illuminating roads and walkways increases safety for pedestrians and cyclists. At the same time, LED technology also helps to save energy.
Kevin Jackson, technical sales engineer for Bayer MaterialScience, comments: “The exhibits we had on display attracted many visitors to the stand which then gave us the opportunity to talk to them more about what we do.
“PDM is important to BMS as it enables the team to make new valuable contacts with engineers and designers, and network with our existing industry contacts.”
PDM2012 is the only dedicated design and moulding event in the UK featuring leading industry companies, and it is the place for plastics and design professionals to network, learn and be inspired. A video of this event can be seen on YouTube: http://www.youtube.com/BayerUKIre
Andrea Postles, Tel. 01635 563 031 E-Mail: email@example.com
About Bayer MaterialScience:
With 2011 sales of EUR 10.8 billion, Bayer MaterialScience is among the world’s largest polymer companies. Business activities are focused on the manufacture of high-tech polymer materials and the development of innovative solutions for products used in many areas of daily life. The main segments served are the automotive, electrical and electronics, construction and the sports and leisure industries. At the end of 2011, Bayer MaterialScience had 30 production sites and employed approximately 14,800 people around the globe. Bayer MaterialScience is a Bayer Group company.
Bayer: Science For A Better Life
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. The company’s products and services are designed to benefit people and improve their quality of life. At the same time Bayer creates value through innovation, growth and high earning power. The Group is committed to the principles of sustainable development and to its role as a socially and ethically responsible corporate citizen. Economy, ecology and social responsibility are corporate policy objectives of equal rank. Globally, in fiscal 2011, Bayer employed more than 112,000 people and had sales of €36.5 billion. Capital expenditures amounted to €1.7 billion, R&D expenses to €2.9 billion. For more information, go to www.bayer.com
Bayer’s offices in the UK and Ireland are located in Newbury (head office), Cambridge, Uxbridge and Dublin. For more information, go to www.bayer.co.uk
Follow us on Twitter at: www.twitter.com/BayerUkIreland
Follow us on YouTube at www.youtube.com/BayerUKIre
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.